Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etelcalcetide on Bone and Vascular Health in ESKD
NCT03960437Phase 2Completed
- Start
- Sep 2018
- Primary completion
- Nov 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etelcalcetide in secondary hyperparathyroidism (SHPT). Started Sep 2018; status: completed.
02
Drugs
etelcalcetide
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT03960437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03960437.